Диссертация (1154715), страница 22
Текст из файла (страница 22)
Crit. Care med. — 2011. — Vol. 184 (5). — P. 602-615.100. El-Radhi, A. Effect of oral glucocorticoid treatment on serum inflammatorymarkers in acute asthma / A. El-Radhi, C. Hogg, J. Bungre, A. Bush, C. Corrigan //Arch. Dis. Child. — 2000. — Vol. 83 (2). — P.
158-162.101. Falcone, M. A defect in interleukin 12-induced activation and interferon gammasecretion of peripheral natural killer T cells in nonobese diabetic mice suggests newpathogenic mechanisms for insulin-dependent diabetes mellitus / M. Falcone, B.Yeung, L. Tucker, E. Rodriguez, N. Sarvetnick // J Exp Med. — 1999.
— Vol. 190 (7).— P. 963-972.145102. Faul, J.L. The Effect of an Inhaled Corticosteroid on Glucose Control in Type 2Diabetes / J.L. Faul, S.R. Wilson, J.W. Chu, J. Canfield, W.G. Kuschner // Clin MedRes. — 2009. — Vol. 7 (1-2). — P. 14-20.103. Forlenza, G.P. The epidemic of type 1 diabetes: what is it telling us? / G.P.Forlenza, M. Rewers // Curr Opin Endocrinol Diabetes Obes.
— 2011. — Vol. 18 (4).— P.248-251.104. Frey, A.B. NKT cell cytokine imbalance in murine diabetes mellitus / A.BFrey, T.D. Rao // Autoimmunity. — 1999. — Vol. 29 (3). —P. 201-214.105. Frühbeck, G. Intracellular signalling pathways activated by leptin / G. Frühbeck// Biochem J.
— 2006. — Vol. 393 (1). — P. 7-20.106. Gazit, V. Atopy in Children and Adolescents with Insulin-Dependent DiabetesMellitus / V. Gazit, D. Tasher, A. Hanukoglu, Z. Landau, Y. Ben-Yehuda, E. Somekh,I. Dalal // IMAJ — 2008. — Vol. 10 (12). — P. 858-861.107. Ghigo, A. PI3K inhibition in inflammation: Toward tailored therapies for specificdiseases / A. Ghigo, F. Damilano, L. Braccini, E. Hirsch // Bioessays.
— 2010. — Vol.32 (3). — P. 185-196.108. Global Report on Diabetes [Электронный ресурс]. — Geneva, Switzerland:WHO,2016.—Режимдоступа:http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf109. Hanania, N.A. Lebrikizumab in moderate-to-severe asthma: pooled data from tworandomised placebo-controlled studies / N.A. Hanania, M.
Noonan, J. Corren, P.Korenblat // Thorax. — 2015. — Vol. 70 (8). — P. 748-756.110. Hansen, L.A. Pulmonary complications in diabetes mellitus / L.A. Hansen, U.B.Prakash, T.V. Colby // Mayo Clin Proc. — 1989. — Vol. 64 (7). — P. 791-799.111. Harder, T.
Birth Weight, Early Weight Gain, and Subsequent Risk of Type 1Diabetes: Systematic Review and Meta-Analysis / T. Harder K. Roepke, N. Diller, Y.Stechling, J.W. Dudenhausen, A. Plagemann // American Journal of Epidemiology. —2009. — Vol. 169 (12). — P. 1428-1436.112. Helander, E. Asthma and diabetes / E. Helander // Acta Med Scand. — 1958. —Vol. 162 (3). — P.
165-174.146113. Higgins, J.P. Quantifying heterogeneity in a meta-analysis / J.P. Higgins, S.G.Thompson // Stat Med. — 2002. — Vol. 21 (11). — P. 1539-1558.114. Huang, S. Influence of TH1/TH2 paradigm: the prevalence of asthma and allergicdiseases in patients with type 1 diabetes / S. Huang, J. Hitchcock //J Allergy ClinImmunol. — 2001. — Vol. 107. — P. 991.115.
Hussain, M.J. Cytokine overproduction in healthy first degree relatives of patientswith IDDM / M.J. Hussain, J. Maher, T. Warnock, A. Vats, M. Peakman, D. Vergani //Diabetologia. — 1998. — Vol. 41 (3). — 343-349.116. Hussain, M.J. Elevated serum levels of macrophage-derived cytokines precedeand accompany the onset of IDDM / M.J. Hussain, M. Peakman, H. Gallati, S.S. Lo, M.Hawa, G.C. Viberti, P.J. Watkins, R.D. Leslie, D. Vergani // Diabetologia.
— 1996. —Vol. 39 (1). — P. 60-69.117. Insuela, D.B.R. The Yin Yang of Hormones that Control Glucose Homeostasis inAsthma / B.R. Insuela Daniella, M.R. Silva Patrícia, M.A. Martins, V. F. Carvalho // JAller Ther. — 2013. — Vol. 11. — 8 p.118. Jarosz-Chobot, P. Rapid increase in the incidence of type 1 diabetes in Polishchildren from 1989 to 2004, and predictions for 2010 to 2025 / P. Jarosz-Chobot, J.Polanska, A. Szadkowska, A. Kretowski, E. Bandurska-Stankiewicz, M. Ciechanowska,G. Deja, M.
Mysliwiec, J. Peczynska, J. Rutkowska, A. Sobel-Maruniak, P. Fichna, A.Chobot, M. Rewers // Diabetologia. — 2011. — Vol. 54 (3). — P. 508-515.119. Jasser-Nitsche H. Type 1 diabetes in children and adolescents is not associatedwith a reduced prevalence of atopy and allergic diseases / H. Jasser-Nitsche, E.M.Varga, Helmuth, H.M. Borkenstein, J. Höntzsch, E.
Suppan, G. Weinhandl, L.Pieringer, A. Avian, E. Fröhlich-Reiterer // Pediatric Diabetes. — 2017. — 5 p.120. Jiang, H. Targeting phosphoinositide 3-kinase γ in airway smooth muscle cells tosuppress interleukin-13-induced mouse airway hyperresponsiveness / H. Jiang, Y. Xie,P.W. Abel, M.L. Toews, R.G. Townley, T.B. Casale, Y. Tu // J Pharmacol Exp Ther. —2012. — Vol. 342 (2). — P. 305-311.121. Jin, S.L.
Phosphodiesterase 4B is essential for T(H)2-cell function anddevelopment of airway hyperresponsiveness in allergic asthma / S.L. Jin, S. Goya, S.147Nakae, D. Wang, M. Bruss, C. Hou, D. Umetsu, M. Conti // J Allergy Clin Immunol. —2010. — Vol. 126 (6). — P. 1252-1259.122. Joslin, E.P.
The treatment of diabetes mellitus: 10th Ed. / E.P. Joslin, H.F. Root,P. White, A. Marble. — Philadelphia, Pennsylvania: Lea and Febiger, 1959. — 798 p.123. Karavanaki, K. Prevalence of allergic symptoms among children with diabetesmellitus type 1 of different socioeconomic status / K. Karavanaki, E. Tsoka, C.Karayianni, V. Petrou, E. Pippidou, M. Brisimitzi, M. Mavrikiou, K. Kakleas, I.Konstantopoulos, M.
Manoussakis, C. Dacou-Voutetakis // Pediatric Diabetes. — 2008.— Vol. 9. — P. 407-416.124. Karlstad, Ø. Comorbidities in an asthma population 8-29 years old: a study fromthe Norwegian Prescription Database / Ø. Karlstad, P. Nafstad, A. Tverdal, S. Skurtveit,K. Furu // Pharmacoepidemiol Drug Saf.
— 2012. — Vol. 21 (10). — P. 1045-1052.125. Keating, G.M. Mepolizumab: First Global Approval / G.M. Keating // Drugs. —2015. — Vol. 75 (18). — P. 2163-2169.126. Kero, J. Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence inchildren with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study /J.
Kero, M. Gissler, E. Hemminki, E. Isolauri // J Allergy Clin Immunol. — 2001. —Vol. 108 (5). — P. 781-783.127. Ker, J. The atopic march: what’s the evidence? / J. Ker, T.V. Hartert // AnnAllergy Asthma Immunol. — 2009. — Vol. 103 (4). — P. 282-289.128. Kidd, P. Th1/Th2 balance: the hypothesis, its limitations, and implications forhealth and disease / P. Kidd // Alter Med Rev. — 2003. — Vol. 8 (3) — P. 223-246.129.
Kim, K.W. Relationship between adipokines and manifestations of childhoodasthma / K.W. Kim, Y.H. Shin, K.E. Lee, E.S. Kim, M.H. Sohn, K.E. Kim // PediatrAllergy Immunol. — 2008. — Vol. 19 (6). — P. 535-540.130. Koga, C. Possible pathogenic role of Th17 cells for atopic dermatitis / C. Koga,K. Kabashima, N. Shiraishi , M. Kobayashi, Y. Tokura // J Invest Dermatol. — 2008.— Vol. 128. — P. 2625-2630.148131. Kouro, T. IL-5- and eosinophil-mediated inflammation: from discovery totherapy / T. Kouro, T.
Takatsu // Int Immunol. — 2009. — Vol. 21 (12). — P.13031309.132. Kudo,M.IL-17AproducedbyalphabetaTcellsdrivesairwayhyperresponsiveness in mice and enhances mouse and human airway smooth musclecontraction / M. Kudo, A.C. Melton, C.
Chen, M.B. Engler, K.E. Huang, X. Ren, Y.Wang, X. Bernstein, J.T. Li, K. Atabai, X. Huang D. Sheppard // Nat Med. — 2012. —Vol. 18 (4). — P. 547-554.133. Kukreja, A. Autoimmunity and diabetes / A. Kukreja, N.K. Maclaren // J ClinEndocrinol Metab. — 1999. — Vol. 84 (12). — P.
4371-4378.134. Larochelle, J. Plasma resistin levels in asthmatics as a marker of disease state / J.Larochelle, J. Freiler, J. Dice, L. Hagan // J Asthma. — 2007. — Vol. 44 (7). — P. 509513.135. Lau, J. Quantitative synthesis in systematic reviews / J. Lau, J.P.
Ioannidis,Schmid C.H. // Ann Intern Med. — 1997. — Vol. 127 (9). — P. 820-826.136. Leslie, R.D. Autoimmune diabetes: Caught in a NET / R.D. Leslie, C. Bradford //Diabetes. — 2014. — Vol. 63 (12). — P. 4018-4020.137. Lessmann, E. Insulin and insulin-like growth factor-1 promote mast cell survivalvia activation of the phosphatidylinositol-3-kinase pathway / E. Lessmann G.Grochowy, L. Weingarten, T. Giesemann, K. Aktories, M. Leitges. G.
Krystal. M.Huber // Exp Hematol. — 2006. — Vol. 34 (11). — P. 1532-1541.138. Licari, A. Omalizumab in Children / A. Licari, A. Marseglia, S. Caimmi, R.Castagnoli, T. Foiadelli, S. Barberi and G.L. Marseglia // Paediatr Drugs. — 2014. —Vol. 16 (6). — P. 491-502.139. Lieberman, S.M. Identification of the beta cell antigen targeted by a prevalentpopulation of pathogenic CD8+ T cells in autoimmune diabetes.
/ S.M. Lieberman,A.M. Evans, B. Han, T. Takak, Y. Vinnitskaya, J.A. Caldwell, D.V. Serreze, J.Shabanowitz, D.F. Hunt, S.G. Nathenson, P. Santamaria, T.P. DiLorenzo // Proc NatlAcad Sci USA. — 2003. — Vol. 100 (14). — P. 8384-8388.149140. Lim, D.H. PI3K gamma-deficient mice have reduced levels of allergen-inducedeosinophilic inflammation and airway remodeling / D.H. Lim, J.Y. Cho, D.J. Song, S.Y.Lee, M. Miller, D.H.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
